Want to join the conversation?
Global accessories, footwear and apparel company $KORS posted 2Q16 diluted EPS of $1.01 vs. $1.00 in 2Q15. There was an acceleration in the North American digital flagship sales in the Retail segment and the company drove sequential improvement in its comp performance.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?